CROWN 5 Yr Update
Phase III CROWN: 5-Yr Update of First-line Lorlatinib vs Crizotinib in Advanced ALK-Positive NSCLC

Released: June 03, 2024

Expiration: June 02, 2025

Activity

Progress
1
Course Completed